Paper

Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy

Published Feb 17, 2021 · H. Bansal, J. Leon, Jeremy L. Pont

Scientific Reports

118

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

RCTRigorous JournalHighly Cited

Study Snapshot

A dose of 10 billion platelets is crucial for long-lasting chondroprotective effects in moderate knee osteoarthritis, with a new manual method of preparation improving platelet recovery up to 90%.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Platelet-rich plasma (PRP) in osteoarthritis (OA) knee: Correct dose critical for long term clinical efficacy

References

Citations